[Reuters] Merck & Co, taking a cue from rival drugmakers that have slashed research spending to bolster earnings, said it will cut annual operating costs by $2.5 billion and eliminate 8,500 jobs, or more than 10 percent of its global workforce. Merck, whose shares rose 2.3 percent, said it aims to narrow its focus to products […]